Aurion Biotech Appoints Edward J. Holland, M.D., and Eris P. Jordan, O.D.
Key leadership appointments to accelerate global clinical development of AURN001, a transformational cell therapy for corneal endothelial disease Aurion Biotech, a clinical-stage regenerative medicine company...